Biobizkaia
Forschungszentrum
Instituto Aragonés de Ciencias de la Salud
Zaragoza, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto Aragonés de Ciencias de la Salud (13)
2024
-
APOE and familial hypercholesterolemia
Current Opinion in Lipidology, Vol. 35, Núm. 4, pp. 195-199
-
Novel risk loci for COVID-19 hospitalization among admixed American populations
eLife, Vol. 13
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Contribution of APOE Genetic Variants to Dyslipidemia
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 43, Núm. 6, pp. 1066-1077
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
PBM: Now more than ever necessary
Revista Espanola de Anestesiologia y Reanimacion, Vol. 69, Núm. 6, pp. 351-354
2021
-
Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia
Revista Espanola de Cardiologia, Vol. 74, Núm. 8, pp. 664-673
-
Preoperative hemogram as a predictive factor for iron deficit and/or transfusion in patients scheduled for arthroplasty
Revista Espanola de Anestesiologia y Reanimacion, Vol. 68, Núm. 10, pp. 555-563
2020
-
Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial
Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25
2016
-
Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects
Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 567-582
-
Opposite cannabis-cognition associations in psychotic patients depending on family history
PLoS ONE, Vol. 11, Núm. 8
2015
-
Réplica a «Emergencia de aislados de Mycobacterium tuberculosis complex resistentes a rifampicina y sensibles a isoniazida»
Enfermedades Infecciosas y Microbiologia Clinica